- Home
- LASR vs KOD Comparison
LASR vs KOD Comparison
Compare LASR & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASR
- KOD
- Stock Information
- Founded
- LASR 2000
- KOD 2009
- Country
- LASR United States
- KOD United States
- Employees
- LASR N/A
- KOD N/A
- Industry
- LASR Semiconductors
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LASR Technology
- KOD Health Care
- Exchange
- LASR Nasdaq
- KOD Nasdaq
- Market Cap
- LASR 903.8M
- KOD 795.5M
- IPO Year
- LASR 2018
- KOD 2018
- Fundamental
- Price
- LASR $33.23
- KOD $22.48
- Analyst Decision
- LASR Strong Buy
- KOD Buy
- Analyst Count
- LASR 6
- KOD 7
- Target Price
- LASR $32.67
- KOD $22.29
- AVG Volume (30 Days)
- LASR 861.7K
- KOD 761.4K
- Earning Date
- LASR 11-06-2025
- KOD 11-13-2025
- Dividend Yield
- LASR N/A
- KOD N/A
- EPS Growth
- LASR N/A
- KOD N/A
- EPS
- LASR N/A
- KOD N/A
- Revenue
- LASR $227,526,000.00
- KOD N/A
- Revenue This Year
- LASR $23.44
- KOD N/A
- Revenue Next Year
- LASR $8.73
- KOD N/A
- P/E Ratio
- LASR N/A
- KOD N/A
- Revenue Growth
- LASR 12.05
- KOD N/A
- 52 Week Low
- LASR $6.20
- KOD $1.92
- 52 Week High
- LASR $38.62
- KOD $23.00
- Technical
- Relative Strength Index (RSI)
- LASR 56.01
- KOD 67.90
- Support Level
- LASR $28.09
- KOD $19.25
- Resistance Level
- LASR $31.31
- KOD $23.00
- Average True Range (ATR)
- LASR 2.55
- KOD 1.98
- MACD
- LASR -0.03
- KOD 0.17
- Stochastic Oscillator
- LASR 49.86
- KOD 96.23
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.